SCHEMBL5886852

SCHEMBL5886852

Cc1nc(N2CCN(Cc3ccccc3)CC2)nc2c1ccc(=O)n2-c1ccc(C(N)=O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.46
ALDH1A1 P00352 4/20 0.46
HTT P42858 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPSR1 Q6W5P4 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MAPK1 P28482 3/20 0.44
TSHR P16473 2/20 0.44
CASP1 P29466 2/20 0.42
CASP5 P51878 2/20 0.42
CASP4 P49662 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5886830 0.89 ALDH1A1 (0.42) LMNAALDH1A1HTTSMN1; SMN2L3MBTL1
SCHEMBL5887366 0.88 ALDH1A1 (0.47) LMNAALDH1A1HTTSMN1; SMN2NPSR1
SCHEMBL5886902 0.88 GBA1 (0.46) ALDH1A1SMN1; SMN2L3MBTL1TSHRMEN1
SCHEMBL5887437 0.86 LMNA (0.57) LMNASMN1; SMN2MAPK1TSHRCASP1
SCHEMBL5887401 0.86 GAA (0.47) LMNAALDH1A1SMN1; SMN2TSHRHDAC6
SCHEMBL5887743 0.85 HDAC1 (0.41) SMN1; SMN2NPSR1MAPK1TSHRHDAC1
SCHEMBL5886744 0.85 MGLL (0.46) LMNAALDH1A1HTTMAPK1TSHR
SCHEMBL5886817 0.85 MGLL (0.36) ALDH1A1TSHRCASP1KMT2AUSP2
SCHEMBL5887184 0.85 CHEK1 (0.46) ALDH1A1HTTSMN1; SMN2MAPK1TSHR
SCHEMBL5886806 0.84 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2L3MBTL1MAPK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7019002-B2 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents PHARMACIA & UPJOHN, S.P.A. (IT) 2006-03-28 US claimed
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors PHARMACIA ITALIA S.P.A. 2004-01-15 US claimed
US-7019002-B2 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents PHARMACIA & UPJOHN, S.P.A. (IT) 2006-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors TERT, TERF2, TERF2IP LMNA 711/4885ALDH1A1 1860/4885HTT 1319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.